CALAMAIO SERENA

Melgari, D., Villa, M., Frosio, A., Calamaio, S., Anastasia, L., Pappone, C., et al. (2025). Functional reassessment of Nav1.5 T559A reveals loss-of-function in a variant commonly used as wild type. AMERICAN JOURNAL OF PHYSIOLOGY. CELL PHYSIOLOGY, 329(2), 585-591 [10.1152/ajpcell.00424.2025]. Dettaglio

Anastasia, L., Tarantino, A., Melgari, D., Piccoli, M., Ciconte, G., Frosio, A., et al. (2025). BS-499656-002 Lethal Autoimmune Channelopathies: Nav1.5 Autoantibodies And Their Role In Sudden Cardiac Death. Intervento presentato a: Heart Rhythm, San Diego, CA [10.1016/j.hrthm.2025.03.117]. Dettaglio

Tarantino, A., Ciconte, G., Melgari, D., Frosio, A., Ghiroldi, A., Piccoli, M., et al. (2024). NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications. EUROPEAN HEART JOURNAL, 45(40), 4336-4348 [10.1093/eurheartj/ehae480]. Dettaglio

Prevostini, R., Frosio, A., Melgari, D., Calamaio, S., Rivolta, I. (2023). How ketogenic diet may be beneficial in controlling neuronal excitability?. Intervento presentato a: NeuroMi - 5 Dicembre 2023, Milano, Italia. Dettaglio

Difrancesco, J., Ragona, F., Murano, C., Frosio, A., Melgari, D., Binda, A., et al. (2023). A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet. EPILEPSIA, 34(12 (December 2023)), 222-228 [10.1111/epi.17777]. Dettaglio